$RFL
Rafael Holdings Inc Stock $rfl

$rfl Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000121390024095111 Filed on November 07, 2024

Income Statement

Concept	2024	2023 Q3
Revenue	$637.0K	$70.00K
YoY Change	128.32%	1.45%
Cost Of Revenue	$154.0K
YoY Change
Gross Profit	$483.0K
YoY Change	73.12%
Gross Profit Margin	75.82%
Selling, General & Admin		$1.400M
YoY Change		-54.07%
% of Gross Profit
Research & Development	$4.170M	$1.270M
YoY Change	-33.94%	-31.02%
% of Gross Profit	863.35%
Depreciation & Amortization		$20.00K
YoY Change		-101.87%
% of Gross Profit
Operating Expenses	$4.170M	$2.680M
YoY Change	-98.71%	-45.38%
Operating Profit	-$102.6M
YoY Change	582.22%
Interest Expense	$248.0K	$4.060M
YoY Change		2003.63%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$67.26M	$1.460M
YoY Change	669.14%	-131.43%
Income Tax	-$2.680M	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$34.41M	$1.220M
YoY Change	1734.22%	-125.5%
Net Earnings / Revenue	-5401.88%	1742.86%
Basic Earnings Per Share	-$1.45
Diluted Earnings Per Share	-$1.45	$0.05
COMMON SHARES
Basic Shares Outstanding	23.75M shares
Diluted Shares Outstanding	23.75M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$66.00M	$79.21M
YoY Change	-16.68%	25.27%
Cash & Equivalents	$2.700M	$21.50M
Short-Term Investments	$63.30M	$57.71M
Other Short-Term Assets		$900.0K
YoY Change		-97.98%
Inventory
Prepaid Expenses
Receivables	$426.0K	$245.0K
Other Receivables		$1.900M
Total Short-Term Assets	$72.50M	$82.94M
YoY Change	-12.59%	-23.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.120M	$1.695M
YoY Change	25.07%	-4.24%
Goodwill	$3.050M
YoY Change
Intangibles	$1.847M	$0.00
YoY Change
Long-Term Investments		$12.60M
YoY Change		140.41%
Other Assets	$35.00K	$9.000K
YoY Change	288.89%	-99.35%
Total Long-Term Assets	$24.33M	$15.89M
YoY Change	53.13%	59.31%
TOTAL ASSETS
Total Short-Term Assets	$72.50M	$82.94M
Total Long-Term Assets	$24.33M	$15.89M
Total Assets	$96.83M	$98.83M
YoY Change	-2.02%	-16.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.556M	$333.0K
YoY Change	667.57%	-40.96%
Accrued Expenses	$1.798M	$763.0K
YoY Change	135.65%	-59.31%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.514M	$2.145M
YoY Change	250.3%	-89.8%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities	$5.000K	$55.00K
YoY Change	-90.91%	-37.5%
Total Long-Term Liabilities	$5.000K	$55.00K
YoY Change	-90.91%	-37.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.514M	$2.145M
Total Long-Term Liabilities	$5.000K	$55.00K
Total Liabilities	$10.57M	$2.200M
YoY Change	380.64%	-89.58%
SHAREHOLDERS EQUITY
Retained Earnings		-$167.3M
YoY Change		1.13%
Common Stock		$264.0M
YoY Change		3300025.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$82.19M	$100.3M
YoY Change
Total Liabilities & Shareholders Equity	$96.83M	$98.83M
YoY Change	-2.02%	-16.47%

Cashflow Statement

Concept	2024	2023 Q3
OPERATING ACTIVITIES
Net Income	-$34.41M	$1.220M
YoY Change	1734.22%	-125.5%
Depreciation, Depletion And Amortization		$20.00K
YoY Change		-101.87%
Cash From Operating Activities	-$7.802M	-$1.450M
YoY Change	-28.33%	-23.76%
INVESTING ACTIVITIES
Capital Expenditures	$143.0K	$0.00
YoY Change		-100.0%
Acquisitions	-$1.099M
YoY Change
Other Investing Activities		$7.410M
YoY Change		-214.67%
Cash From Investing Activities	-$10.82M	$7.410M
YoY Change	-151.01%	-216.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$179.0K	-40.00K
YoY Change	-98.82%	-100.67%
NET CHANGE
Cash From Operating Activities	-$7.802M	-1.450M
Cash From Investing Activities	-$10.82M	7.410M
Cash From Financing Activities	-$179.0K	-40.00K
Net Change In Cash	-$18.82M	5.920M
YoY Change	273.55%	-359.42%
FREE CASH FLOW
Cash From Operating Activities	-$7.802M	-$1.450M
Capital Expenditures	$143.0K	$0.00
Free Cash Flow	-$7.945M	-$1.450M
YoY Change	-27.02%	-27.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	rfl	Impairment Of Cost Method Investment Rafael Pharmaceuticals ImpairmentOfCostMethodInvestmentRafaelPharmaceuticals		usd
CY2024	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	200000	usd
CY2024	rfl	Consideration For Acquisition Of Day Three Included In Accrued Expenses ConsiderationForAcquisitionOfDayThreeIncludedInAccruedExpenses	200000	usd
CY2024	rfl	Elimination Of Principal And Accrued Interest On The Day Three Promissory Note Included In Cons EliminationOfPrincipalAndAccruedInterestOnTheDayThreePromissoryNoteIncludedInCons	2000000	usd
CY2024	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	742000	usd
CY2024	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	3142000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	1499000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	63000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	77000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	408000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	3050000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	2180000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	386000	usd
CY2024Q1	rfl	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses	98000	usd
CY2024Q1	rfl	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Installment Note Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesInstallmentNotePayable	2500000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	4293000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	1151000	usd
CY2024Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	3142000	usd
CY2024Q3	us-gaap	Accounts Payable Interest Bearing Current And Noncurrent AccountsPayableInterestBearingCurrentAndNoncurrent	2500000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1700000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	3100000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2514970	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2514970	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.71
CY2023Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2100000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4000000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4000000	shares
CY2023Q3	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5000000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2514970	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.40	pure
CY2024Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	12009630	usd
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	4763102	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.80	pure
CY2024	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.80	pure
CY2024Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	63300000	usd
CY2024	us-gaap	Debt Securities Trading Unrealized Gain DebtSecuritiesTradingUnrealizedGain	2000	usd
CY2024	us-gaap	Debt Securities Trading Unrealized Loss DebtSecuritiesTradingUnrealizedLoss	37000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	63265000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	57988000	usd
CY2023	us-gaap	Debt Securities Trading Unrealized Gain DebtSecuritiesTradingUnrealizedGain	4386000	usd
CY2023	us-gaap	Debt Securities Trading Unrealized Loss DebtSecuritiesTradingUnrealizedLoss	4660000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	57714000	usd
CY2024	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	1800000	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	154000	usd
CY2024	rfl	Treasury Bills Term TreasuryBillsTerm	P1Y
CY2022Q3	us-gaap	Interest Expense Federal Funds Purchased InterestExpenseFederalFundsPurchased	49400000	usd
CY2024Q3	us-gaap	Other Notes Payable OtherNotesPayable	15000000	usd
CY2024	us-gaap	Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax	33000000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	249000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	468000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-219000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	87000	usd
CY2023	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-306000	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	6784000	usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-07-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-55863
CY2024	dei	Entity Registrant Name EntityRegistrantName	RAFAEL HOLDINGS, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-2296593
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 Broad Street
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07102
CY2024	dei	City Area Code CityAreaCode	(212)
CY2024	dei	Local Phone Number LocalPhoneNumber	658-1450
CY2024	dei	Security12b Title Security12bTitle	Class B common stock, par value $0.01 per share
CY2024	dei	Trading Symbol TradingSymbol	RFL
CY2024	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Public Float EntityPublicFloat	34400000	usd
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	596
CY2024	dei	Auditor Name AuditorName	CohnReznick LLP
CY2024	dei	Auditor Location AuditorLocation	New York, New York
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2675000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21498000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	63265000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	57714000	usd
CY2024Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	515000	usd
CY2023Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	387000	usd
CY2024Q3	rfl	Convertible Note Receivables Due From Cyclo ConvertibleNoteReceivablesDueFromCyclo	5191000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	245000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	245000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	426000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	213000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	430000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	914000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	294000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	72502000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	82941000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2120000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1695000	usd
CY2024Q3	rfl	Convertible Note Receivable Noncurrent ConvertibleNoteReceivableNoncurrent	1146000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	3050000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1847000	usd
CY2024Q3	rfl	Inprocess Research And Development Noncurrent InprocessResearchAndDevelopmentNoncurrent	1575000	usd
CY2023Q3	rfl	Inprocess Research And Development Noncurrent InprocessResearchAndDevelopmentNoncurrent	1575000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	6478000	usd
CY2024	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	6800000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9000	usd
CY2024Q3	us-gaap	Assets Assets	96832000	usd
CY2023Q3	us-gaap	Assets Assets	98829000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2556000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	333000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1798000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	763000	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	614000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	113000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1023000	usd
CY2024Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1700000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7514000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2145000	usd
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2982000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	73000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	55000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	10574000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2200000	usd
CY2024Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	168000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	111000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-353000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	3691000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	3725000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	82185000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	100293000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	4073000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-3664000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	86258000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	96629000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96832000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	98829000	usd
CY2024	us-gaap	Revenues Revenues	637000	usd
CY2023	us-gaap	Revenues Revenues	279000	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	154000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8854000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8932000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4170000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6312000	usd
CY2024	rfl	Inprocess Research And Development Expense InprocessResearchAndDevelopmentExpense	89861000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	225000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	78000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-102627000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-15043000	usd
CY2024	us-gaap	Interest Income Other InterestIncomeOther	2383000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	3253000	usd
CY2023	rfl	Impairment Of Cost Method Investment Rafael Pharmaceuticals ImpairmentOfCostMethodInvestmentRafaelPharmaceuticals	334000	usd
CY2024	rfl	Loss On Initial Investment In Day Three Upon Acquisition LossOnInitialInvestmentInDayThreeUponAcquisition	1633000	usd
CY2024	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	1772000	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	154000	usd
CY2024	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-46000	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	309000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	33000	usd
CY2024	rfl	Realized Gain In Equity Investments Cyclo Therapeutics Inc RealizedGainInEquityInvestmentsCycloTherapeuticsInc	424000	usd
CY2024	rfl	Unrealizedloss Gain On Investment Cyclo Therapeutics Inc UnrealizedlossGainOnInvestmentCycloTherapeuticsInc	37000	usd
CY2023	rfl	Unrealizedloss Gain On Investment Cyclo Therapeutics Inc UnrealizedlossGainOnInvestmentCycloTherapeuticsInc	2663000	usd
CY2024	rfl	Unrealized Gain On Convertible Notes Receivable Due From Cyclo UnrealizedGainOnConvertibleNotesReceivableDueFromCyclo	1191000	usd
CY2024	rfl	Unrealized Gain On Investment Hedge Funds UnrealizedGainOnInvestmentHedgeFunds	63000	usd
CY2023	rfl	Unrealized Gain On Investment Hedge Funds UnrealizedGainOnInvestmentHedgeFunds	220000	usd
CY2024	rfl	Recovery Of Receivables From Cornerstone RecoveryOfReceivablesFromCornerstone	31305000	usd
CY2024	us-gaap	Interest Expense InterestExpense	248000	usd
CY2024	us-gaap	Other Income OtherIncome	118000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-67261000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8745000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2680000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-255000	usd
CY2024	rfl	Equity In Losses Of Day Three Labs Inc EquityInLossesOfDayThreeLabsInc	422000	usd
CY2023	rfl	Equity In Losses Of Day Three Labs Inc EquityInLossesOfDayThreeLabsInc	203000	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-65003000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8693000	usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-306000	usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	6784000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	6478000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-65003000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2215000	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-30593000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-339000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-34410000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1876000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-65003000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2215000	usd
CY2024	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	464000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-290000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	53000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	42000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-64592000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2547000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-30595000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-336000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33997000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2211000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.45
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.45
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.36
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.36
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.28
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.28
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.45
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23745516	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23745516	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23263211	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23263211	shares
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	96629000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-65003000	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2296000	usd
CY2024	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	136000	usd
CY2024	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	464000	usd
CY2024	rfl	Stock Issued During Period Value Sale Of Rafael Medical Devices Membership Units StockIssuedDuringPeriodValueSaleOfRafaelMedicalDevicesMembershipUnits	-925000	usd
CY2024	rfl	Noncontrolling Interest In Day Three Acquisition NoncontrollingInterestInDayThreeAcquisition	1151000	usd
CY2024	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	168000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	7600000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	7260000	usd
CY2024	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	27501000	usd
CY2024	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	12667000	usd
CY2024	rfl	Stock Issued During Period Value Elimination Of Rp Finance Investment In Cornerstone StockIssuedDuringPeriodValueEliminationOfRPFinanceInvestmentInCornerstone	-4931000	usd
CY2024	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	56000	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-53000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	86258000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	97206000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2215000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3091000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	903000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	218000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-290000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-42000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	96629000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-65003000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2215000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	6478000	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-65003000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8693000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	225000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	78000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	27000	usd
CY2024	rfl	Unrealized Gain On Investment Hedge Funds UnrealizedGainOnInvestmentHedgeFunds	63000	usd
CY2023	rfl	Unrealized Gain On Investment Hedge Funds UnrealizedGainOnInvestmentHedgeFunds	220000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	33000	usd
CY2024	us-gaap	Gain Loss On Investments GainLossOnInvestments	-46000	usd
CY2024	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	1772000	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	154000	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1891000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1195000	usd
CY2023	rfl	Impairment Of Cost Method Investment ImpairmentOfCostMethodInvestment	334000	usd
CY2024	rfl	Loss On Initial Investment In Day Three Upon Acquisition LossOnInitialInvestmentInDayThreeUponAcquisition	1633000	usd
CY2024	rfl	Realized Gain In Equity Investments RealizedGainInEquityInvestments	424000	usd
CY2024	rfl	Unrealized Gain In Equity Investments UnrealizedGainInEquityInvestments	-37000	usd
CY2023	rfl	Unrealized Gain In Equity Investments UnrealizedGainInEquityInvestments	-2663000	usd
CY2024	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1191000	usd
CY2024	rfl	Recovery Of Receivables RecoveryOfReceivables	-31305000	usd
CY2024	rfl	Inprocess Research And Development Expense InprocessResearchAndDevelopmentExpense	89861000	usd
CY2024	rfl	Gain On Dissolution Of A Business GainOnDissolutionOfABusiness	18000	usd
CY2024	rfl	Equity In Loss EquityInLoss	422000	usd
CY2023	rfl	Equity In Loss EquityInLoss	203000	usd
CY2024	us-gaap	Provision For Other Losses ProvisionForOtherLosses	20000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2296000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2188000	usd
CY2024	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	150000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	117000	usd
CY2024	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	139000	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	247000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-673000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-373000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-22000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	27000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-146000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-827000	usd
CY2024	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-938000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	781000	usd
CY2024	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	138000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-43000	usd
CY2024	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-70000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	15000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7802000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10247000	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-639000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7802000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10886000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	143000	usd
CY2024	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	155657000	usd
CY2023	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	204798000	usd
CY2024	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	153352000	usd
CY2023	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	185121000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	270000	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	35000	usd
CY2024	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	271000	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	1325000	usd
CY2024	rfl	Issuance Of Convertible Notes Due From Cyclo IssuanceOfConvertibleNotesDueFromCyclo	-4000000	usd
CY2023	rfl	Issuance Of Convertible Note Receivable Related Party IssuanceOfConvertibleNoteReceivableRelatedParty	2000000	usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	3000000	usd
CY2024	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6786000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2100000	usd
CY2024	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000	usd
CY2024	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	1989000	usd
CY2024	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	42000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	78000	usd
CY2023	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	1586000	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-1099000	usd
CY2024	rfl	Cash Acquired In The Cornerstone Acquisition Net Of Cash Payments CashAcquiredInTheCornerstoneAcquisitionNetOfCashPayments	-1256000	usd
CY2024	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	2500000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10820000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-26960000	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	49400000	usd
CY2023	rfl	Payment To Fund Rp Finance Line Of Credit PaymentToFundRPFinanceLineOfCredit	1229000	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	48171000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10820000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21211000	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	800000	usd
CY2024	rfl	Payments For Taxes Related To Shares Withheld For Employee Taxes PaymentsForTaxesRelatedToSharesWithheldForEmployeeTaxes	136000	usd
CY2023	rfl	Payments For Taxes Related To Shares Withheld For Employee Taxes PaymentsForTaxesRelatedToSharesWithheldForEmployeeTaxes	218000	usd
CY2024	rfl	Purchases Of Treasury Stock PurchasesOfTreasuryStock	168000	usd
CY2024	us-gaap	Proceeds From Distributions Received From Real Estate Partnerships ProceedsFromDistributionsReceivedFromRealEstatePartnerships	49400000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	40200000	usd
CY2024	rfl	Transaction Costs TransactionCosts	1200000	usd
CY2024	us-gaap	Disposal Group Including Discontinued Operation Rental Income DisposalGroupIncludingDiscontinuedOperationRentalIncome	1200000	usd
CY2024	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	925000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-179000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-218000	usd
CY2023	rfl	Payment Of Note Payable In Connection With Sale Of Property Discontinued Operations PaymentOfNotePayableInConnectionWithSaleOfPropertyDiscontinuedOperations	15000000	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-15000000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-179000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15218000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-22000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-146000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18823000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5039000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21498000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26537000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2675000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21498000	usd
CY2023	rfl	Acquisition Of Additional Ownership Interest In Lipo Medix AcquisitionOfAdditionalOwnershipInterestInLipoMedix	16000	usd
CY2024	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	37845000	usd
CY2024	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2663000	usd
CY2024	rfl	Recognition Of Noncontrolling Interest In The Cornerstone Acquisition RecognitionOfNoncontrollingInterestInTheCornerstoneAcquisition	27501000	usd
CY2024	rfl	Recognition Of Noncontrolling Interest In The Rp Finance Consolidation Net Of Elimination RecognitionOfNoncontrollingInterestInTheRPFinanceConsolidationNetOfElimination	9585000	usd
CY2024	rfl	Gain On Rp Finance Consolidation Recorded As An Adjustment To Additional Paidin Capital Due To R GainOnRPFinanceConsolidationRecordedAsAnAdjustmentToAdditionalPaidinCapitalDueToR	5751000	usd
CY2024	rfl	Other Receivable Recognized Related To Sale Of Patent OtherReceivableRecognizedRelatedToSaleOfPatent	34000	usd
CY2024	rfl	Elimination Of Principal And Accrued Interest On The Day Three Promissory Notes Included In Cons EliminationOfPrincipalAndAccruedInterestOnTheDayThreePromissoryNotesIncludedInCons	2000000	usd
CY2024Q1	rfl	Issued And Outstanding Ordinary Shares Percentage IssuedAndOutstandingOrdinarySharesPercentage	0.67	pure
CY2023Q3	us-gaap	Other Ownership Interests Value OtherOwnershipInterestsValue	925000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates.</p>
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2700000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	63300000	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration of Credit Risk and Significant Customers</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company routinely assesses the financial strength of its customers. As a result, the Company believes that its accounts receivable credit risk exposure is limited.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of July 31, 2024, there was one related party which represented 50% of the Company’s accounts receivable balance. As of July 31, 2023, there was one customer which represented 27% of the Company’s accounts receivable balance and one related party which represented 47% of the Company’s accounts receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended July 31, 2024, one customer represented 51% of total revenue, and one tenant and one related party tenant represented 27% and 17% of the Company’s revenue, respectively. For the year ended July 31, 2023, including revenue from discontinued operations, a related party tenant represented 42% of the Company’s revenue.</p>
CY2024	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	20000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2024	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Long-Lived Assets<b> </b></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equipment, buildings, leasehold improvements, and furniture and fixtures are recorded at cost less accumulated depreciation and amortization. The related depreciation and amortization are computed using the straight-line method over the estimated useful lives, which range as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Classification</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Building and improvements</td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">40</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Tenant improvements</td><td> </td> <td style="text-align: center">7-15</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: center">3-5</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other (primarily office equipment, furniture and fixtures)</td><td> </td> <td style="text-align: center">5</td></tr> </table>
CY2024	rfl	Schedule Of Estimated Useful Lives Of Long Lived Assets ScheduleOfEstimatedUsefulLivesOfLongLivedAssets	Equipment, buildings, leasehold improvements, and furniture and fixtures are recorded at cost less accumulated depreciation and amortization. The related depreciation and amortization are computed using the straight-line method over the estimated useful lives, which range as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Classification</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Building and improvements</td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">40</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Tenant improvements</td><td> </td> <td style="text-align: center">7-15</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: center">3-5</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other (primarily office equipment, furniture and fixtures)</td><td> </td> <td style="text-align: center">5</td></tr> </table>
CY2024Q3	us-gaap	Other Assets OtherAssets	84159000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	69676000	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2024Q1	rfl	Outstanding Voting Interest OutstandingVotingInterest	0.67	pure
CY2024	rfl	Approximately Outstanding Percentage ApproximatelyOutstandingPercentage	0.94	pure
CY2024	rfl	Aggregate Principal And Accrued Interest Amount AggregatePrincipalAndAccruedInterestAmount	900000	usd
CY2024	rfl	Outstanding Principal And Accrued Interest OutstandingPrincipalAndAccruedInterest	30600000	usd
CY2024	rfl	Fair Value Of Purchase Consideration FairValueOfPurchaseConsideration	7300000	usd
CY2024	rfl	Recognizing Gain RecognizingGain	600000	usd
CY2024	rfl	Rp Finance Shares RPFinanceShares	3658368	shares
CY2024	rfl	Percentage Of Outstanding Common Stock Of Cornerstone PercentageOfOutstandingCommonStockOfCornerstone	0.06	pure
CY2024Q3	us-gaap	Investments And Cash InvestmentsAndCash	1500000	usd
CY2024	rfl	Percentage Of Diluted Capital Stock PercentageOfDilutedCapitalStock	0.10	pure
CY2024	rfl	Percentage Of Issued And Outstanding Common Stock PercentageOfIssuedAndOutstandingCommonStock	0.67	pure
CY2024	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	37845000	usd
CY2024	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2663000	usd
CY2024	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1500000	usd
CY2024	rfl	Fair Valueof Consideration Paid FairValueofConsiderationPaid	42008000	usd
CY2024	rfl	Noncontrolling Interest Arising From Cornerstone Acquisition NoncontrollingInterestArisingFromCornerstoneAcquisition	27501000	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	69509000	usd
CY2024	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	716000	usd
CY2024	rfl	Percentage Of Total Probability PercentageOfTotalProbability	1	pure
CY2024Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	0	usd
CY2024Q3	rfl	Due From Cornerstone DueFromCornerstone	720000	usd
CY2024	rfl	Iprd Expense IPRDExpense	89900000	usd
CY2024	rfl	Percentage Of Additional Equity Interest PercentageOfAdditionalEquityInterest	0.375	pure
CY2024	rfl	Cornerstone Amount CornerstoneAmount	0	usd
CY2024	rfl	Acquired Rp Finance Investment AcquiredRPFinanceInvestment	4900000	usd
CY2024	rfl	Post Reverse Stock Split PostReverseStockSplit	3919598	shares
CY2024	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	637000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	279000	usd
CY2024	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-15803000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-117234000	usd
CY2024	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-6745000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-42483000	usd
CY2024	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-280
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1830
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23745516	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23263211	shares
CY2024	rfl	Percentage Of Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent PercentageOfConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent	0.90	pure
CY2024	rfl	Principal Due Accrued Interest PrincipalDueAccruedInterest	25000000	usd
CY2024	rfl	Promissory Note PromissoryNote	2000000	usd
CY2024	rfl	Promissory Note Interest Rate1 PromissoryNoteInterestRate1	0.075	pure
CY2024	rfl	Receivable Balance Due ReceivableBalanceDue	720000	usd
CY2024	rfl	Equity Interest Rate EquityInterestRate	0.375	pure
CY2024	rfl	Percentage Of Rp Finance Line Of Credit PercentageOfRPFinanceLineOfCredit	0.375	pure
CY2024	rfl	Percentage Of Issued And Outstanding Share PercentageOfIssuedAndOutstandingShare	0.12	pure
CY2024Q3	rfl	Fully Diluted Basis Percentage FullyDilutedBasisPercentage	0.10	pure
CY2024	rfl	Fully Diluted Capital Stock FullyDilutedCapitalStock	0.10	pure
CY2024	rfl	Percentage Of Issued And Outstanding Equity PercentageOfIssuedAndOutstandingEquity	0.51	pure
CY2020Q1	rfl	Percentage Of Issued And Outstanding Share PercentageOfIssuedAndOutstandingShare	0.12	pure
CY2024Q3	rfl	Ownership Interests OwnershipInterests	0.375	pure
CY2024	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.035	pure
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	10000000	usd
CY2024Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.25
CY2024	rfl	Price Per Share Percentage PricePerSharePercentage	0.90	pure
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	614000	usd
CY2024Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	70000	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	654000	usd
CY2023Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	403000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	437000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	276000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	441000	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	7000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	213000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	53000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	77000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1798000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	763000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2982000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4780000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	763000	usd
CY2023Q2	us-gaap	Noninterest Expense Related To Performance Fees NoninterestExpenseRelatedToPerformanceFees	10500000	usd
CY2023Q3	us-gaap	Recapitalization Costs RecapitalizationCosts	2000000	usd
CY2024	us-gaap	Additional Liability Long Duration Insurance Issuance AdditionalLiabilityLongDurationInsuranceIssuance	2000000	usd
CY2023Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	100000000	usd
CY2024	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Fair Value Acquired ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired	4000000	usd
CY2024	us-gaap	Long Term Debt Average Amount Outstanding LongTermDebtAverageAmountOutstanding	2500000	usd
CY2024	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	2000000	usd
CY2024Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	2700000	usd
CY2024	us-gaap	Interest Expense Other InterestExpenseOther	237000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	3000000	usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	1000000	usd
CY2021Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2021-09-01
CY2021Q3	us-gaap	Investment Interest Rate InvestmentInterestRate	0.15	pure
CY2021Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2022-11-11
CY2024Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.84	pure
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Other Carrying Amount RedeemableNoncontrollingInterestEquityOtherCarryingAmount	8000	usd
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.95	pure
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Other Carrying Amount RedeemableNoncontrollingInterestEquityOtherCarryingAmount	16000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.79	pure
CY2024	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	200000	usd
CY2024	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	200000	usd
CY2024	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	2000000	usd
CY2024Q3	us-gaap	Interests Continued To Be Held By Transferor Fair Value InterestsContinuedToBeHeldByTransferorFairValue	700000	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	65000	usd
CY2024Q3	rfl	Accounts Receivable Third Party AccountsReceivableThirdParty	338000	usd
CY2023Q3	rfl	Accounts Receivable Third Party AccountsReceivableThirdParty	247000	usd
CY2024Q3	rfl	Accounts Receivable Related Party AccountsReceivableRelatedParty	333000	usd
CY2023Q3	rfl	Accounts Receivable Related Party AccountsReceivableRelatedParty	211000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	245000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	245000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	426000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	213000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3138000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2573000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1018000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	878000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2120000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1695000	usd
CY2024	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	3050000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	3050000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1935000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	88000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1847000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	148000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	132000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	123000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	123000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	123000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1198000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1847000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	88000	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1246949	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1073175	shares
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-65003000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8693000	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-30593000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-339000	usd
CY2024	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	-34410000	usd
CY2023	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	-8354000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	6478000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34410000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1876000	usd
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23745516	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23745516	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23263211	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23263211	shares
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.45
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.45
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.36
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.36
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.28
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.28
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.45
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	296000	usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	313000	usd
CY2024Q3	us-gaap	Area Of Land AreaOfLand	80000	sqft
CY2024	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	108000	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	211000	usd
CY2023Q3	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	19000	usd
CY2024	rfl	Revenue Percentage RevenuePercentage	0.17	pure
CY2023	rfl	Revenue Percentage RevenuePercentage	0.42	pure
CY2023	rfl	Aggregate Voting Percentage AggregateVotingPercentage	0.513	pure
CY2024	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	19000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	19000	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2602000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-274000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-2583000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-255000	usd
CY2024	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-73000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-17000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-7000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-97000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2680000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-255000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-14213000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1877000	usd
CY2024	rfl	Income Tax Reconciliation Permanent Items Cornerstone Acquisition IncomeTaxReconciliationPermanentItemsCornerstoneAcquisition	18871000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	672000	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1807000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-479000	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-583000	usd
CY2024	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	627000	usd
CY2024	rfl	Income Tax Reconciliation Cornerstone Acquisition Impact To Deferred Tax IncomeTaxReconciliationCornerstoneAcquisitionImpactToDeferredTax	-51546000	usd
CY2024	rfl	Income Tax Reconciliation Derecognition Of Cornerstone Investment Due To Cornerstone Acquisition IncomeTaxReconciliationDerecognitionOfCornerstoneInvestmentDueToCornerstoneAcquisition	23312000	usd
CY2024	rfl	Income Tax Reconciliation Sales Of State No Ls IncomeTaxReconciliationSalesOfStateNOLs	-2613000	usd
CY2023	rfl	Income Tax Reconciliation Sales Of State No Ls IncomeTaxReconciliationSalesOfStateNOLs	-274000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20404000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2958000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2680000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-255000	usd
CY2024	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	2600000	usd
CY2024Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	31600000	usd
CY2023	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	274000	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3300000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61204000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17852000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	30236000	usd
CY2024Q3	rfl	Deferred Tax Assets Rd Credits Net Of Uncertain Tax Position DeferredTaxAssetsRDCreditsNetOfUncertainTaxPosition	6145000	usd
CY2024Q3	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3121000	usd
CY2023Q3	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	689000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2486000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1858000	usd
CY2024Q3	rfl	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	286000	usd
CY2023Q3	rfl	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	-1000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	249000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	237000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	141000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71362000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	50871000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71275000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50871000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2357000	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	2327000	usd
CY2024Q3	rfl	Deferred Tax Liabilities Amortization DeferredTaxLiabilitiesAmortization	30000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2357000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6218000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6218000	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2024	rfl	Total Revenue Percentage TotalRevenuePercentage	1	pure
CY2023	rfl	Total Revenue Percentage TotalRevenuePercentage	0.53	pure
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2120000	usd
CY2024Q3	us-gaap	Assets Assets	96832000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1695000	usd
CY2023Q3	us-gaap	Assets Assets	98829000	usd
CY2024	us-gaap	Cost Maintenance CostMaintenance	20000000	usd
CY2024	us-gaap	Royalty Expense RoyaltyExpense	10000000	usd
CY2024	rfl	Escalation Amount EscalationAmount	1000000000	usd
CY2024	rfl	Termination Of The License Agreement TerminationOfTheLicenseAgreement	P90D
CY2024	rfl	Breach Of License Agreement BreachOfLicenseAgreement	P30D
CY2017Q2	rfl	Royalty Term RoyaltyTerm	P5Y
CY2017Q2	rfl	Expiration Of Licensed Patent Term ExpirationOfLicensedPatentTerm	P8Y
CY2024	us-gaap	Management And Service Fees Rate ManagementAndServiceFeesRate	0.50	pure
CY2024	rfl	Restricted Stock Units Description RestrictedStockUnitsDescription	On August 24, 2021, the Company issued 2,833,425 shares of Class B common stock (the “Institutional Shares”), par value $0.01 per share, to the Institutional Investors, at a purchase price equal to $35.00 per share, for aggregate gross proceeds of approximately $99.2 million, before deducting placement agent fees and other offering expenses.
CY2021Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	98000000	usd
CY2021Q3	rfl	Deducting Transaction Costs DeductingTransactionCosts	6200000	usd
CY2022Q3	rfl	Aggregate Sale Price AggregateSalePrice	6000000	usd
CY2022Q2	rfl	Employment Agreement Term EmploymentAgreementTerm	P5Y
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	600000	usd
CY2024Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	294000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1021277	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.11
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y5M19D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	175000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.08
CY2023	rfl	Weighted Average Remaining Contractual Termin Years Granted WeightedAverageRemainingContractualTerminYearsGranted	P9Y6M3D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	589205	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	218663	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	388409	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.51
CY2023	rfl	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P8Y8M15D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	250000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.84
CY2024	rfl	Weighted Average Remaining Contractual Termin Years Granted WeightedAverageRemainingContractualTerminYearsGranted	P9Y6M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	638409	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.55
CY2024	rfl	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P8Y4M20D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	114602	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.13
CY2024	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y7M9D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.34
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.58
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	193000	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1004341	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	24.17
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2024	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	472000	shares
CY2003Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	625000	shares
CY2024	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.10	pure
CY2024	rfl	Percentage Of Rp Finance Top Up Shares PercentageOfRPFinanceTopUpShares	0.06	pure
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	33360	shares
CY2022Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	986835	shares
CY2022Q1	rfl	Restricted Shares Vested Percentage RestrictedSharesVestedPercentage	0.24	pure
CY2022Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	452130	shares
CY2023Q1	us-gaap	Selling Expense SellingExpense	307913	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	915000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	135000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1507373	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.22
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	220019	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.99
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	745867	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.37
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	296759	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.1
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	684766	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.04
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	506826	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.75
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	583052	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.15
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	608540	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.99
CY2024	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2000000	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3044000	usd
CY2024	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	296000	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	194000	usd
CY2023	rfl	Forfeiture Of Rs Us Within General And Administrative ForfeitureOfRSUsWithinGeneralAndAdministrative	-931000	usd
CY2023	rfl	Forfeiture Of Rs Us Within Research And Development ForfeitureOfRSUsWithinResearchAndDevelopment	-119000	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2296000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2188000	usd
CY2024	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	22.91
CY2024	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The Company is the lessor of the Israeli property which is leased to tenants under net operating leases with a term expiration date within 2025.
CY2024	us-gaap	Lease Income LeaseIncome	282000	usd
CY2023	us-gaap	Lease Income LeaseIncome	279000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	78000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	78000	usd
CY2024	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	A related party has the right to terminate the Israeli lease upon four months’ notice.
CY2024	rfl	Exchange Ratio Description ExchangeRatioDescription	(x) $0.95 by (y) the sum of the (A) Total Net Cash Amount, plus (B) Total Loan Amount, divided by the total number of shares of Rafael Capital Stock outstanding at the First Effective Time, including any shares of Rafael Capital Stock issuable upon exercise or conversion of outstanding securities of Rafael with exercise or conversion prices that are no greater than 150% of the then market price for the Rafael Class B common stock.
CY2024	rfl	Acquisition Pre Funding Closing Amount AcquisitionPreFundingClosingAmount	25000000	usd
CY2024	rfl	Merger Agreement Incurred Related Costs MergerAgreementIncurredRelatedCosts	250000	usd
CY2024Q3	us-gaap	Liabilities Subject To Compromise Early Contract Termination Fees LiabilitiesSubjectToCompromiseEarlyContractTerminationFees	400000	usd
CY2023Q3	rfl	Convertible Note Receivables Due From Cyclo ConvertibleNoteReceivablesDueFromCyclo		usd
CY2024Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi		usd
CY2023Q3	rfl	Convertible Note Receivable Noncurrent ConvertibleNoteReceivableNoncurrent		usd
CY2023Q3	us-gaap	Goodwill Goodwill		usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent		usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities		usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue		usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	rfl	Inprocess Research And Development Expense InprocessResearchAndDevelopmentExpense		usd
CY2023	rfl	Loss On Initial Investment In Day Three Upon Acquisition LossOnInitialInvestmentInDayThreeUponAcquisition		usd
CY2024	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023	rfl	Realized Gain In Equity Investments Cyclo Therapeutics Inc RealizedGainInEquityInvestmentsCycloTherapeuticsInc		usd
CY2023	rfl	Unrealized Gain On Convertible Notes Receivable Due From Cyclo UnrealizedGainOnConvertibleNotesReceivableDueFromCyclo		usd
CY2023	rfl	Recovery Of Receivables From Cornerstone RecoveryOfReceivablesFromCornerstone		usd
CY2023	us-gaap	Interest Expense InterestExpense		usd
CY2023	us-gaap	Other Income OtherIncome		usd
CY2024	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax		usd
CY2024	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2024	rfl	Impairment Of Cost Method Investment ImpairmentOfCostMethodInvestment		usd
CY2023	rfl	Loss On Initial Investment In Day Three Upon Acquisition LossOnInitialInvestmentInDayThreeUponAcquisition		usd
CY2023	rfl	Realized Gain In Equity Investments RealizedGainInEquityInvestments		usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
CY2023	rfl	Recovery Of Receivables RecoveryOfReceivables		usd
CY2023	rfl	Inprocess Research And Development Expense InprocessResearchAndDevelopmentExpense		usd
CY2023	rfl	Gain On Dissolution Of A Business GainOnDissolutionOfABusiness		usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses		usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	rfl	Issuance Of Convertible Notes Due From Cyclo IssuanceOfConvertibleNotesDueFromCyclo		usd
CY2024	rfl	Issuance Of Convertible Note Receivable Related Party IssuanceOfConvertibleNoteReceivableRelatedParty		usd
CY2024	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2023	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable		usd
CY2024	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	rfl	Cash Acquired In The Cornerstone Acquisition Net Of Cash Payments CashAcquiredInTheCornerstoneAcquisitionNetOfCashPayments		usd
CY2023	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund		usd
CY2024	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2024	rfl	Payment To Fund Rp Finance Line Of Credit PaymentToFundRPFinanceLineOfCredit		usd
CY2024	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023	rfl	Purchases Of Treasury Stock PurchasesOfTreasuryStock		usd
CY2023	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock		usd
CY2024	rfl	Payment Of Note Payable In Connection With Sale Of Property Discontinued Operations PaymentOfNotePayableInConnectionWithSaleOfPropertyDiscontinuedOperations		usd
CY2024	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2024	rfl	Acquisition Of Additional Ownership Interest In Lipo Medix AcquisitionOfAdditionalOwnershipInterestInLipoMedix		usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023	rfl	Recognition Of Noncontrolling Interest In The Cornerstone Acquisition RecognitionOfNoncontrollingInterestInTheCornerstoneAcquisition		usd
CY2023	rfl	Recognition Of Noncontrolling Interest In The Rp Finance Consolidation Net Of Elimination RecognitionOfNoncontrollingInterestInTheRPFinanceConsolidationNetOfElimination		usd
CY2023	rfl	Gain On Rp Finance Consolidation Recorded As An Adjustment To Additional Paidin Capital Due To R GainOnRPFinanceConsolidationRecordedAsAnAdjustmentToAdditionalPaidinCapitalDueToR		usd
CY2023	rfl	Other Receivable Recognized Related To Sale Of Patent OtherReceivableRecognizedRelatedToSaleOfPatent		usd
CY2023	rfl	Elimination Of Principal And Accrued Interest On The Day Three Promissory Notes Included In Cons EliminationOfPrincipalAndAccruedInterestOnTheDayThreePromissoryNotesIncludedInCons		usd
CY2024	rfl	Reported Valueof Previously Held Interests ReportedValueofPreviouslyHeldInterests		usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2023Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent		usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization		usd
CY2023Q3	us-gaap	Goodwill Goodwill		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	rfl	Income Tax Reconciliation Permanent Items Cornerstone Acquisition IncomeTaxReconciliationPermanentItemsCornerstoneAcquisition		usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems		usd
CY2023	rfl	Income Tax Reconciliation Cornerstone Acquisition Impact To Deferred Tax IncomeTaxReconciliationCornerstoneAcquisitionImpactToDeferredTax		usd
CY2023	rfl	Income Tax Reconciliation Derecognition Of Cornerstone Investment Due To Cornerstone Acquisition IncomeTaxReconciliationDerecognitionOfCornerstoneInvestmentDueToCornerstoneAcquisition		usd
CY2024Q3	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities		usd
CY2023Q3	rfl	Deferred Tax Assets Rd Credits Net Of Uncertain Tax Position DeferredTaxAssetsRDCreditsNetOfUncertainTaxPosition		usd
CY2023Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards		usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2023Q3	rfl	Deferred Tax Liabilities Amortization DeferredTaxLiabilitiesAmortization		usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2024	us-gaap	Open Tax Year OpenTaxYear	2020
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q3	rfl	Aggregate Intrinsic Value Outstanding Granted AggregateIntrinsicValueOutstandingGranted		usd
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	rfl	Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Remaining Contractual Term Expired SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingContractualTermExpired
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	rfl	Weighted Average Remaining Contractual Termin Years Cancelled Forfeited WeightedAverageRemainingContractualTerminYearsCancelledForfeited
CY2023Q3	rfl	Aggregate Intrinsic Value Cancelled Forfeited AggregateIntrinsicValueCancelledForfeited		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	rfl	Aggregate Intrinsic Value Outstanding Granted AggregateIntrinsicValueOutstandingGranted		usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024	rfl	Forfeiture Of Rs Us Within General And Administrative ForfeitureOfRSUsWithinGeneralAndAdministrative		usd
CY2024	rfl	Forfeiture Of Rs Us Within Research And Development ForfeitureOfRSUsWithinResearchAndDevelopment		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001713863

Files In Submission

Name	View Source	Status
0001213900-24-095111-index-headers.html	Edgar Link	pending
0001213900-24-095111-index.html	Edgar Link	pending
0001213900-24-095111.txt	Edgar Link	pending
0001213900-24-095111-xbrl.zip	Edgar Link	pending
ea0217275-10k_rafael.htm	Edgar Link	pending
ea021727501ex10-4_rafael.htm	Edgar Link	pending
ea021727501ex21-01_rafael.htm	Edgar Link	pending
ea021727501ex23-1_rafael.htm	Edgar Link	pending
ea021727501ex31-01_rafael.htm	Edgar Link	pending
ea021727501ex31-02_rafael.htm	Edgar Link	pending
ea021727501ex32-01_rafael.htm	Edgar Link	pending
ea021727501ex32-02_rafael.htm	Edgar Link	pending
ea021727501ex4-2_rafael.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0217275-10k_rafael_htm.xml	Edgar Link	completed
R106.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
rfl-20240731.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rfl-20240731_cal.xml	Edgar Link	unprocessable
rfl-20240731_def.xml	Edgar Link	unprocessable
rfl-20240731_pre.xml	Edgar Link	unprocessable
rfl-20240731_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RFL
Rafael Holdings Inc Stock $rfl

2024 Q3 Form 10-K Financial Statement

#000121390024095111 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RFL Rafael Holdings Inc Stock $rfl

2024 Q3 Form 10-K Financial Statement

#000121390024095111 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RFL
Rafael Holdings Inc Stock $rfl